Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress Syndrome
Condition(s):COVID-19 Acute Respiratory Distress SyndromeLast Updated:April 15, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19 Acute Respiratory Distress SyndromeLast Updated:April 15, 2022Recruiting
Condition(s):Acute Respiratory Distress SyndromeLast Updated:May 6, 2023Recruiting
Condition(s):Acute Respiratory Distress SyndromeLast Updated:June 3, 2019Unknown status
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:December 3, 2012Unknown status
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:May 21, 2019Completed
Condition(s):Acute Respiratory Distress SyndromeLast Updated:June 23, 2023Terminated
Condition(s):Acute Respiratory Distress SyndromeLast Updated:July 2, 2021Completed
Condition(s):Acute Respiratory Distress SyndromeLast Updated:May 15, 2023Recruiting
Condition(s):Acute Respiratory Distress Syndrome ARDSLast Updated:March 26, 2024Not yet recruiting
Condition(s):Early Prediction for Sepsis Induced Acute Lung InjuryLast Updated:June 18, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.